EUVIMEDEUVIMED entdecken
Crossref

Integrated proteomic and glycoproteomic analysis reveals heterogeneity and molecular signatures of brain metastases from lung adenocarcinomas

Yang Zhao, Dainan Zhang, Bo Meng, Yong Zhang, Shunchang Ma, Jiaming Zeng, Xi Wang, Tao Peng, Xiaoyun Gong, Rui Zhai, Lianhua Dong, You Jiang und 3 weitere

Cancer Letters · 2024-11 · 605 · 217262

DOI: 10.1016/j.canlet.2024.217262 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2024-11. Verfasst von Yang Zhao und 14 weiteren Autor:innen. Beteiligte Einrichtung: Technology Innovation Center of Mass Spectrometry for State Market Regulation, Center for Advanced Measurement Science, National Institute of Metrolo…. Hauptthemen laut MEDLINE: Brain Neoplasms, Adenocarcinoma of Lung, Proteomics, Lung Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 78 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Brain metastasis is a major cause of poor prognosis and death in lung adenocarcinoma (LUAD); however, the understanding of therapeutic strategies and mechanisms for brain metastases from LUAD (BM-LUAD) remains notably limited, especially at the proteomics levels. To address this issue, we conducted integrated proteomic and glycoproteomic analyses on 49 BM-LUAD tumors, revealing two distinct subtypes of the disease: BM-S1 and BM-S2. Whole exome sequencing analysis revealed that somatic mutations in STK11 and KEAP1, as well as copy number deletions on chr19p13.3, such as STK11, UQCR11, and SLC25A23, were more frequently detected in BM-S2. In BM-S1 tumors, we observed significant infiltration of GFAP + astrocytes, as evidenced by elevated levels of GFAP, GABRA2, GABRG1 and GAP43 proteins and an enrichment of astrocytic signatures in both our proteomic data and external spatial transcriptomic data. Conversely, BM-S2 tumors demonstrated higher levels of PD-1 immune cell infiltration, supported by the upregulation of PD-1 and LAG-3 genes. These findings suggest distinct microenvironmental adaptations required by the different BM-LUAD subtypes. Additionally, we observed unique glycosylation patterns between the subtypes, with increased fucosylation in BM-S1 and enhanced sialylation in BM-S2, primarily affected by glycosylation enzymes such as FUT9, B4GALT1, and ST6GAL1. Specifically, in BM-S2, these sialylation modifications are predominantly localized to the lysosomes, underscoring the critical role of N-glycosylation in the tumor progression of BM-LUAD. Overall, our study not only provides a comprehensive multi-omic data resource but also offers valuable biological insights into BM-LUAD, highlighting potential mechanisms and therapeutic targets for further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsAdenocarcinoma of LungProteomicsLung NeoplasmsHumansFemaleMaleGlycoproteinsBiomarkers, TumorMutationMiddle AgedTumor MicroenvironmentExome Sequencing

Stichwörter der Autor:innen

AstrocytesBrain metastasesGlycoproteomicsLUADProteomics

Substanzen

GlycoproteinsBiomarkers, Tumor

Autor:innen und Institutionen

  • Technology Innovation Center of Mass Spectrometry for State Market Regulation, Center for Advanced Measurement Science, National Institute of Metrology, Beijing, 100029, China.
  • Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China; Beijing Neurosurgical Institute, Capital Medical University, Beijing, 100070, China.
  • Institutes for Systems Genetics, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Technology Innovation Center of Mass Spectrometry for State Market Regulation, Center for Advanced Measurement Science, National Institute of Metrology, Beijing, 100029, China. Electronic address: daixh@nim.ac.cn.
  • Technology Innovation Center of Mass Spectrometry for State Market Regulation, Center for Advanced Measurement Science, National Institute of Metrology, Beijing, 100029, China. Electronic address: fangxiang@nim.ac.cn.
  • Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China; Beijing Neurosurgical Institute, Capital Medical University, Beijing, 100070, China. Electronic address: noanswea…

Zitieren

APA

Zhao, Y., Zhang, D., Meng, B., Zhang, Y., Ma, S., Zeng, J., Wang, X., Peng, T., Gong, X., Zhai, R., Dong, L., Jiang, Y., Dai, X., Fang, X., & Jia, W. (2024). Integrated proteomic and glycoproteomic analysis reveals heterogeneity and molecular signatures of brain metastases from lung adenocarcinomas. Cancer Letters, 605, 217262. https://doi.org/10.1016/j.canlet.2024.217262

Vancouver

Zhao Y, Zhang D, Meng B, Zhang Y, Ma S, Zeng J, et al. Integrated proteomic and glycoproteomic analysis reveals heterogeneity and molecular signatures of brain metastases from lung adenocarcinomas. Cancer Letters. 2024;605:217262. doi:10.1016/j.canlet.2024.217262

BibTeX
@article{Zhao2024,
  author = {Zhao, Yang and Zhang, Dainan and Meng, Bo and Zhang, Yong and Ma, Shunchang and Zeng, Jiaming and Wang, Xi and Peng, Tao and Gong, Xiaoyun and Zhai, Rui and Dong, Lianhua and Jiang, You and Dai, Xinhua and Fang, Xiang and Jia, Wang},
  title = {Integrated proteomic and glycoproteomic analysis reveals heterogeneity and molecular signatures of brain metastases from lung adenocarcinomas},
  journal = {Cancer Letters},
  year = {2024},
  volume = {605},
  pages = {217262},
  doi = {10.1016/j.canlet.2024.217262}
}
Kostenlos starten →